Search research articles
Contact Us
Filters
Showing results (11-20 of 37) with videos related to
Page
of 4
Sort By:
Journal for Immunotherapy of Cancer
|
June 16, 2021
Pan-cancer analysis of <i>CD274</i> (PD-L1) mutations in 314,631 patient samples and subset correlation with PD-L1 protein expression
Richard S P Huang, Brennan Decker, Karthikeyan Murugesan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 9, 2025
LRP1b Loss Predicts Sensitivity to Immunotherapy in Patients with NSCLC: An Analysis of the Phase III CheckMate-026 Randomized Trial
Andrew J Armstrong, Hilary Dietz, David Balli, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 9, 2022
Quantifying the Value of Multigene Testing in Resected Early Stage Lung Adenocarcinoma
Bharathi Muthusamy, Kira Raskina, Katherine T Lofgren, et al.
JTO Clinical and Research Reports
|
September 12, 2022
Complementary Roles for Tissue- and Blood-Based Comprehensive Genomic Profiling for Detection of Actionable Driver Alterations in Advanced NSCLC
Lee S Schwartzberg, Gerald Li, Khaled Tolba, et al.
JAMA Network Open
|
October 29, 2020
Prevalence of High Tumor Mutational Burden and Association With Survival in Patients With Less Common Solid Tumors
Changxia Shao, Gerald Li, Lingkang Huang, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 2, 2025
Validation of comprehensive genomic profiling for prognostic and potential therapeutic molecular classification of endometrial cancer
Brian M Slomovitz, Natalie Danziger, Julia C F Quintanilha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 16, 2025
Association of Homologous Recombination Repair Alterations With Outcomes in Patients with Metastatic Hormone-Sensitive Prostate Cancer
Chadi Hage Chehade, Ryon P Graf, Zeynep Irem Ozay, et al.
JCO Precision Oncology
|
June 7, 2024
Predictive Impact of Tumor Mutational Burden on Real-World Outcomes of First-Line Immune Checkpoint Inhibition in Metastatic Melanoma
Miles C Andrews, Gerald Li, Ryon P Graf, et al.
The Oncologist
|
February 24, 2024
Real-World Clinical Performance of a DNA-Based Comprehensive Genomic Profiling Assay for Detecting Targetable Fusions in Nonsquamous NSCLC
Philip C Mack, Rachel B Keller-Evans, Gerald Li, et al.
Journal for Immunotherapy of Cancer
|
January 17, 2023
Durable responders in advanced NSCLC with elevated TMB and treated with 1L immune checkpoint inhibitor: a real-world outcomes analysis
Richard S P Huang, David P Carbone, Gerald Li, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 37) with videos related to
Sort By:
Page
of 4
Journal for Immunotherapy of Cancer
|
June 16, 2021
Pan-cancer analysis of <i>CD274</i> (PD-L1) mutations in 314,631 patient samples and subset correlation with PD-L1 protein expression
Richard S P Huang, Brennan Decker, Karthikeyan Murugesan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 9, 2025
LRP1b Loss Predicts Sensitivity to Immunotherapy in Patients with NSCLC: An Analysis of the Phase III CheckMate-026 Randomized Trial
Andrew J Armstrong, Hilary Dietz, David Balli, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 9, 2022
Quantifying the Value of Multigene Testing in Resected Early Stage Lung Adenocarcinoma
Bharathi Muthusamy, Kira Raskina, Katherine T Lofgren, et al.
JTO Clinical and Research Reports
|
September 12, 2022
Complementary Roles for Tissue- and Blood-Based Comprehensive Genomic Profiling for Detection of Actionable Driver Alterations in Advanced NSCLC
Lee S Schwartzberg, Gerald Li, Khaled Tolba, et al.
JAMA Network Open
|
October 29, 2020
Prevalence of High Tumor Mutational Burden and Association With Survival in Patients With Less Common Solid Tumors
Changxia Shao, Gerald Li, Lingkang Huang, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 2, 2025
Validation of comprehensive genomic profiling for prognostic and potential therapeutic molecular classification of endometrial cancer
Brian M Slomovitz, Natalie Danziger, Julia C F Quintanilha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 16, 2025
Association of Homologous Recombination Repair Alterations With Outcomes in Patients with Metastatic Hormone-Sensitive Prostate Cancer
Chadi Hage Chehade, Ryon P Graf, Zeynep Irem Ozay, et al.
JCO Precision Oncology
|
June 7, 2024
Predictive Impact of Tumor Mutational Burden on Real-World Outcomes of First-Line Immune Checkpoint Inhibition in Metastatic Melanoma
Miles C Andrews, Gerald Li, Ryon P Graf, et al.
The Oncologist
|
February 24, 2024
Real-World Clinical Performance of a DNA-Based Comprehensive Genomic Profiling Assay for Detecting Targetable Fusions in Nonsquamous NSCLC
Philip C Mack, Rachel B Keller-Evans, Gerald Li, et al.
Journal for Immunotherapy of Cancer
|
January 17, 2023
Durable responders in advanced NSCLC with elevated TMB and treated with 1L immune checkpoint inhibitor: a real-world outcomes analysis
Richard S P Huang, David P Carbone, Gerald Li, et al.
Page
of 4